Submission to the Medicines Classification Committee
A doctor may reasonably check MMA and homocysteine rather than dismissing the possibility on the strength of the total
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
This is a prescription medicine, administered by qualified medical practitioners
There is no clinical consensus on timing
She was born and raised in Ohio and always wanted to be a part of the healthcare field